RavenQuest BioMed Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RVVQF research report →
Companywww.rqbglobal.com
RavenQuest BioMed Inc. , a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis.
- CEO
- David Allen Cross
- IPO
- 2018
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $1.24K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.47
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 63.75%
- Op Margin
- -1366.43%
- Net Margin
- -2423.87%
- ROE
- -203.42%
- ROIC
- -47.28%
Growth & Income
- Revenue
- $1.26M · 1018.82%
- Net Income
- $-30,468,000 · -822.99%
- EPS
- $-0.33 · -230.00%
- Op Income
- $-17,176,000
- FCF YoY
- -830.24%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 4.04
- Avg Volume
- 1.31K
Get TickerSpark's AI analysis on RVVQF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RVVQF Coverage
We haven't published any research on RVVQF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RVVQF Report →